ESC 365 - AKAP signalling in chemotherapy-induced heart disease.

Open Access

AKAP signalling in chemotherapy-induced heart disease.

Session: Mechanisms of cancer-related cardiomyopathy

Topic: Myocardium

Speaker: Associate Professor D. Diviani (Lausanne, CH)

Event: Frontiers in CardioVascular Biology 2016

Congress Presentation

Add to my library

About the speaker

Associate Professor Dario Diviani

Lausanne (Switzerland)

1 presentation

0 follower

5 more presentations in this session

Sexual dimorphism of anthracycline cardiotoxicity

Speaker: Doctor M. Moulin (Chatenay-Malabry, FR)

Targeting PI3Kgamma in cancer therapy: how to kill two birds with one stone.

Speaker: Associate Professor A. Ghigo (Turin, IT)

Protection against chemotherapy cardiotoxicity by the human amniotic fluid stem cell secretome: a new tool for future paracrine therapy.

Speaker: Assistant Professor S. Bollini (Genoa, IT)

Hyperlipidaemia reduces mortality in breast, prostate, lung and bowel cancer

Speaker: Doctor P. Carter (Cambridge, GB)

DNA-repair in cardiomyocytes is critical for maintaining cardiac function

Speaker: Miss M. De Boer (Rotterdam, NL)

Access the full session

Mechanisms of cancer-related cardiomyopathy

Speakers: Associate Professor D. Diviani, Doctor M. Moulin, Associate Professor A. Ghigo, Assistant Professor S. Bollini, Doctor P. Carter...

About the event

Frontiers in CardioVascular Biology 2016

8 July - 10 July 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources